<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01787760</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1561AC</org_study_id>
    <nct_id>NCT01787760</nct_id>
  </id_info>
  <brief_title>Controlling Myopia Progression With Soft Contact Lenses</brief_title>
  <official_title>Controlling Myopia Progression With Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate whether novel soft contact lens optical designs can slow myopia
      progression.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Axial Length (Axial Elongation)</measure>
    <time_frame>Baseline and every 6 months post-baseline up to 3 years</time_frame>
    <description>Axial Length was measured with the IOLMaster at baseline, and then every 6 months throughout the course of the study. Five measurements were collected for each eye at each visit and the average of the 5 measurements were used for the analysis. Higher values of axial elongation indicate worse vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spherical Equivalent Refraction</measure>
    <time_frame>Baseline and every 6 months post-baseline up to 3 years</time_frame>
    <description>Spherical Equivalent Refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values of spherical refraction indicate progression in Myopia.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">221</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Test Soft Contact Lens B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lenses will be worn in a daily disposable modality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Soft Contact Lens C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lenses will be worn in a daily disposable modality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spectacle Lenses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control spectacle lenses worn daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Soft Contact Lens B</intervention_name>
    <description>Test lenses to be worn in daily wear modality</description>
    <arm_group_label>Test Soft Contact Lens B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Soft Contact Lens C</intervention_name>
    <description>Test lenses to be worn in a daily wear modality</description>
    <arm_group_label>Test Soft Contact Lens C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Comparator</intervention_name>
    <description>Control spectacle lenses to be worn in a daily wear modality</description>
    <arm_group_label>Spectacle Lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must be between 8 and 12 years of age and of Asia origin.

          2. The subject's best sphere contact lens correction must lie between -0.75D (best of the
             two eyes) and -5.00D (worst of the two eyes)

          3. Astigmatism must be less than or equal to 1.00D

          4. Less than 1.00D difference in spherical equivalent between the two eyes

          5. The subject must have a best-corrected visual acuity of 20/25 and spherical equivalent
             refraction visual acuity of 20/25 or better in both eyes

          6. The subject must have at least 8D of accommodation.

          7. The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED
             CONSENT and the subject must read and sign the Child's Assent Form and be provided a
             copy of each form

          8. The subject must appear able and willing to adhere to the instructions set forth in
             the clinical protocol

        Exclusion Criteria:

          1. Ocular or systemic allergies or diseases that may interfere with contact lens wear

          2. Systemic disease or autoimmune disease or use of medication (e.g. antihistamines),
             which may interfere with contact lens wear.

          3. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that
             might interfere with contact lens wear.

          4. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining, or any other abnormality of the cornea, which may contraindicate contact
             lens wear.

          5. Any ocular infection.

          6. Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          7. Any infectious disease (e.g. hepatitis, tuberculosis) or immunosuppressive disease
             (e.g. HIV).

          8. Diabetes.

          9. Anismetropia.

         10. Astigmatism of greater than 1.00D in either eye.

         11. Eye injury or eye surgery within eight weeks immediately prior to enrollment for this
             study.

         12. Previous refractive surgery, rigid contact lens wear, orthokeratology, keratoconus, or
             other corneal irregularity in either eye

         13. Strabismus in either eye

         14. Pupil or lid abnormality or infection in either eye

         15. Central corneal scar and aphakia in either eye

         16. Contraindications to contact lens wear such as dry eye or history of prior
             unsuccessful contact lens wear

         17. History of participation in clinical trials aimed to control myopia progression

         18. Surgically altered eyes, ocular infection of any type, ocular inflammation

         19. Subject has anterior chamber angle grade 2 or narrower
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Hong Kong Polytechnic University</name>
      <address>
        <city>Hung Hom</city>
        <state>Kowloon</state>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2013</study_first_submitted>
  <study_first_submitted_qc>February 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2013</study_first_posted>
  <results_first_submitted>July 1, 2015</results_first_submitted>
  <results_first_submitted_qc>July 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 29, 2015</results_first_posted>
  <last_update_submitted>May 4, 2016</last_update_submitted>
  <last_update_submitted_qc>May 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of those 221 screened subjects, 56 were ineligible to participate in the study and 13 were eligible but not randomized to the study lens groups.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test Soft Contact Lens B</title>
          <description>Lenses will be worn in a daily disposable modality</description>
        </group>
        <group group_id="P2">
          <title>Test Soft Contact Lens C</title>
          <description>Lenses will be worn in a daily disposable modality</description>
        </group>
        <group group_id="P3">
          <title>Spectacle Lenses</title>
          <description>Control spectacle lenses worn daily.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Anisometropia &gt; -1.00D in spherical equi</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Decompensated on left exotropia</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Dryness</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lens discomfort</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lens handling difficulty</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Stroke</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unsatisfactory lens fitting performance</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unsatisfactory physiological response</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unsatisfactory visual response</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Near vision blur</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline summary was conducted on all randomized subjects.</population>
      <group_list>
        <group group_id="B1">
          <title>Test Soft Contact Lens B</title>
          <description>Lenses will be worn in a daily disposable modality</description>
        </group>
        <group group_id="B2">
          <title>Test Soft Contact Lens C</title>
          <description>Lenses will be worn in a daily disposable modality</description>
        </group>
        <group group_id="B3">
          <title>Spectacle Lenses</title>
          <description>Control spectacle lenses worn daily.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="51"/>
            <count group_id="B4" value="152"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.5" spread="1.1"/>
                    <measurement group_id="B2" value="9.6" spread="1.1"/>
                    <measurement group_id="B3" value="9.5" spread="1.1"/>
                    <measurement group_id="B4" value="9.5" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Axial Length (Axial Elongation)</title>
        <description>Axial Length was measured with the IOLMaster at baseline, and then every 6 months throughout the course of the study. Five measurements were collected for each eye at each visit and the average of the 5 measurements were used for the analysis. Higher values of axial elongation indicate worse vision.</description>
        <time_frame>Baseline and every 6 months post-baseline up to 3 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Spectacle Lenses</title>
            <description>Control spectacle lenses worn daily.</description>
          </group>
          <group group_id="O2">
            <title>Test Soft Contact Lens B</title>
            <description>Lenses will be worn in a daily disposable modality.</description>
          </group>
          <group group_id="O3">
            <title>Test Soft Contact Lens C</title>
            <description>Lenses will be worn in a daily disposable modality.</description>
          </group>
        </group_list>
        <measure>
          <title>Axial Length (Axial Elongation)</title>
          <description>Axial Length was measured with the IOLMaster at baseline, and then every 6 months throughout the course of the study. Five measurements were collected for each eye at each visit and the average of the 5 measurements were used for the analysis. Higher values of axial elongation indicate worse vision.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>millimeter (mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months; N=96, N=70, N=72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.158" spread="0.0981"/>
                    <measurement group_id="O2" value="0.144" spread="0.0834"/>
                    <measurement group_id="O3" value="0.121" spread="0.0749"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months; N=96, N=68, N=74</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.242" spread="0.1448"/>
                    <measurement group_id="O2" value="0.236" spread="0.1267"/>
                    <measurement group_id="O3" value="0.222" spread="0.1288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months; N=92, N=54, N=72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.348" spread="0.2129"/>
                    <measurement group_id="O2" value="0.355" spread="0.1837"/>
                    <measurement group_id="O3" value="0.344" spread="0.1676"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months; N=92, N=54, N=72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.455" spread="0.2520"/>
                    <measurement group_id="O2" value="0.409" spread="0.2247"/>
                    <measurement group_id="O3" value="0.445" spread="0.2444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 30 months; N=70, N=40, N=58</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.565" spread="0.2941"/>
                    <measurement group_id="O2" value="0.512" spread="0.2634"/>
                    <measurement group_id="O3" value="0.511" spread="0.2564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 36 months; N=16, N=8, N=10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.640" spread="0.3199"/>
                    <measurement group_id="O2" value="0.634" spread="0.3249"/>
                    <measurement group_id="O3" value="0.512" spread="0.3072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Spherical Equivalent Refraction</title>
        <description>Spherical Equivalent Refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values of spherical refraction indicate progression in Myopia.</description>
        <time_frame>Baseline and every 6 months post-baseline up to 3 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Spectacle Lenses</title>
            <description>Control spectacle lenses worn daily.</description>
          </group>
          <group group_id="O2">
            <title>Test Soft Contact Lens B</title>
            <description>Lenses will be worn in a daily disposable modality.</description>
          </group>
          <group group_id="O3">
            <title>Test Soft Contact Lens C</title>
            <description>Lenses will be worn in a daily disposable modality.</description>
          </group>
        </group_list>
        <measure>
          <title>Spherical Equivalent Refraction</title>
          <description>Spherical Equivalent Refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values of spherical refraction indicate progression in Myopia.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>diopter (D)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months; N=96, N=70, N=70</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.238" spread="0.3443"/>
                    <measurement group_id="O2" value="-0.327" spread="0.3038"/>
                    <measurement group_id="O3" value="-0.230" spread="0.3436"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months; N=96, N=68, N=72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.417" spread="0.4557"/>
                    <measurement group_id="O2" value="-0.456" spread="0.3733"/>
                    <measurement group_id="O3" value="-0.429" spread="0.4199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months; N=92, N=54, N=70</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.562" spread="0.5841"/>
                    <measurement group_id="O2" value="-0.692" spread="0.3965"/>
                    <measurement group_id="O3" value="-0.720" spread="0.4988"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months; N=92, N=54, N=70</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.776" spread="0.6185"/>
                    <measurement group_id="O2" value="-0.781" spread="0.4447"/>
                    <measurement group_id="O3" value="-0.861" spread="0.5504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 30 months; N=70, N=40, N=56</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.966" spread="0.7592"/>
                    <measurement group_id="O2" value="-1.000" spread="0.5485"/>
                    <measurement group_id="O3" value="-1.003" spread="0.6829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 36 months; N=16, N=8, N=10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.073" spread="0.9922"/>
                    <measurement group_id="O2" value="-1.266" spread="0.3193"/>
                    <measurement group_id="O3" value="-0.824" spread="0.8244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spectacle Lenses</title>
          <description>Control spectacle lenses worn daily.</description>
        </group>
        <group group_id="E2">
          <title>Test Soft Contact Lens B</title>
          <description>Lenses will be worn in a daily disposable modality.</description>
        </group>
        <group group_id="E3">
          <title>Test Soft Contact Lens C</title>
          <description>Lenses will be worn in a daily disposable modality.</description>
        </group>
        <group group_id="E4">
          <title>Not Randomized</title>
          <description>Subjects who met the all study eligible criteria but did not randomize to the study arm.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Slit-lamp finding</sub_title>
                <description>Slit Lamp findings Grade 2 or less requiring treatment.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="51"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>XU CHENG, PRINCIPAL CLINICAL SCIENTIST</name_or_title>
      <organization>Vistakon, USA</organization>
      <phone>1 904 443-1245</phone>
      <email>xcheng6@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

